TESTED AMOUNTS / DRUG REMAINING IN BLOOD
What do PT-141 dosage numbers actually measure?
Bremelanotide is a medicine tested in shots for women’s low desire. The approved shot holds 1.75 milligrams, each a thousandth of a gram; about 2.7 hours pass before the drug remaining in blood halves.
What’s the difference between a shot amount and time in blood?
PT-141 tests measure the drug given and the drug remaining in blood. You can read these figures as study facts, rather than personal instructions.
The approved shot contains 1.75 milligrams, a unit for tiny weights, beneath the skin [7]. Instructions specify at least 45 minutes before sex, with limits of one shot in 24 hours and 8 per month.
Only the specified women’s treatment falls within those medicine instructions. Your doctor must consider your health before deciding about treatment.
About 2.7 hours pass before blood contains half as much drug [7]. That doesn’t mean desire falls by half at the same time.
Researchers gave other amounts through different methods in earlier tests. Products offered for experiments lack medicine checks, so those test amounts can’t guide their use.
PT-141 dosage: how did the amounts differ between tests?
The prescription instructions concern women with the specified distressing loss of desire, before their periods end. They specify a shot holding 1.75 milligrams, placed beneath skin when needed at least 45 minutes before sex, with limits of one in 24 hours and 8 monthly [7].
Blood pressure can briefly rise after treatment. Warnings rule out use when high pressure isn’t controlled, or heart disease or blood vessel disease is known [7].
A tested amount alone can’t settle a decision about your treatment. Your doctor must weigh possible harm alongside any hoped-for improvement.
Smaller Phase 2 trials in women compared 0.75, 1.25, and 1.75 milligram shots. Researchers chose 1.75 milligrams for the later trials in women [3].
Men’s earlier nose-spray tests used about 7-20 milligrams. A separate early safety study called Phase 1, concerning excess weight, used up to 2.5 milligrams, up to three times daily for 15 days [13].
That weight study concerned women with excess weight, rather than the men’s erection tests. Neither research use was an approved treatment.
How long does PT-141 last compared with the wish for sex?
Blood tests after a shot find about half the earlier amount of drug remaining at 2.7 hours [7]. Nose-spray studies also measured how quickly drug amounts in blood fell [13].
Proteins, materials the body makes that can hold onto medicines, carried about 21% of the drug in blood [7]. The measurement describes how the drug travels, rather than how long desire lasts.
The drug breaks apart inside the body, which clears the remains in stool and urine [7]. A blood test may find far less drug than earlier, but that result doesn’t tell you when increased interest in sex ends or whether your desire has returned to what’s usual.
In the scan study, women described increased desire for up to 24 hours [5]. You can see why time in blood and time feeling desire aren’t interchangeable.
PT-141 dosage for women: what supports the chosen amount?
The prescription instructions specify a shot holding 1.75 milligrams when needed [7]. That PT-141 dosage for women concerns the approved treatment before menopause.
Large Phase 3 trials followed 1,267 women receiving 1.75 milligrams over 24 weeks. The women wanted sex more and were less bothered by their loss of desire [3].
A 52-week follow-up found continued desire gains in women staying on treatment [4]. Approval still doesn’t include women who have passed menopause.
Earlier PT-141 female-rat tests found more efforts to attract a male [2]. Back arching during mounting, ordinary movement, and time between mating attempts didn’t increase.
The rat findings supported asking whether women might feel more desire. Animal behavior couldn’t establish how much medicine a woman would receive.
Your age and health add questions beyond a study’s chosen amount. A trial figure alone can’t settle a treatment decision for you.